SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Northrop Grumman Corp. engages in the provision of advanced aircraft systems. It operates through the following segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The Aeronautics Systems segment is involved in the design, development, production, integration, sustainment, and modernization of advanced aircraft systems for the U.S. Air Force, the U.S. Navy, other U.S. government agencies, and international customers. The Defense Systems segment includes integrated battle management systems, weapons systems and aircraft, and mission systems sustainment and modernization. The Mission Systems segment offers advanced mission solutions and multifunction systems, primarily for the U.S. defense and intelligence community, and international customers. The Space Systems segment delivers end-to-end mission solutions through the design, development, integration, production and operation of space, missile defense, launch and strategic missile systems for national security, civil government, commercial, and international customers. The company was founded by John K. Northrop, Thomas V. Jones, and Kent Kresa in 1939 and is headquartered in Falls Church, VA.

Northrop Grumman Corp.

Northrop Grumman is trending as investors digest a positive earnings report that showcased robust international sales and defense contract wins, helping the stock decouple from broader sector volatility. The community is actively discussing the company's solid execution in key missile and space programs, which contrast favorably against recent performance struggles faced by some of its primary defense peers.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney is trending as investors react to the company naming theme park head Josh D'Amaro as the new CEO to succeed Bob Iger, a move designed to stabilize leadership and drive growth. While some community members are optimistic about the potential for a strategic turnaround and value at current price levels, many investors remain skeptical, pointing to long-term stock stagnation and ongoing concerns regarding content strategy and high debt levels.

The Coca-Cola Co. engages in the manufacturing and marketing of non-alcoholic beverages. It operates through the following segments: Europe, Middle East and Africa, Latin America, North America, Asia Pacific, Global Ventures, and Bottling Investments. The company was founded by Asa Griggs Candler on May 8, 1886 and is headquartered in Atlanta, GA.

Coca-Cola Co

Coca-Cola is trending as investors rotate into defensive consumer staples amid ongoing market volatility and tariff concerns, viewing the stock as a reliable "Dividend King" with consistent cash flow. The community is actively debating the company's valuation premium and its strategic leadership transition, while also monitoring its defensive performance against broader tech-led market swings.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is trending as investors react to a series of positive news, including expanded collaborations with Department of Energy national laboratories and anticipation surrounding its upcoming Analyst Day. The community is actively discussing the company's competitive position in the quantum sector, with many long-term bulls highlighting its strategic military and government partnerships while debating the potential impact of volatility following its recent market debut.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is currently garnering significant investor attention following a series of new FDA approvals and positive clinical data for its oncology and immunology portfolios, which are helping drive bullish sentiment despite ongoing legal headwinds related to historical talc litigation. Market participants are actively tracking the company's progress toward its aggressive long-term revenue targets while debating whether this growth momentum can effectively offset the structural challenges posed by upcoming patent expirations and sector-wide regulatory pressures.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

Investors are aggressively rotating capital into the Energy sector as the blockade of the Strait of Hormuz intensifies, driving crude oil toward historic highs and fueling concerns over a prolonged energy-driven inflation shock. The community is heavily focused on the geopolitical risk premium, with traders debating whether to hedge against recession or bet on sustained momentum in major energy producers.

Asana, Inc. engages in the business of developing a work management platform that helps organizations orchestrate work from daily tasks to cross-functional strategic initiatives. The company was founded by Dustin Moskovitz and Justin Michael Rosenstein on December 16, 2008 and is headquartered in San Francisco, CA.

Asana Inc - Ordinary Shares - Class A

Asana Inc

Asana is seeing significant market activity driven by aggressive insider buying from CEO Dustin Moskovitz, which has sparked intense community speculation about potential M&A or a take-private scenario. While some investors are bullish on the company's long-term pivot toward AI-integrated workflows and current valuation, others remain skeptical due to ongoing profitability challenges and competitive pressure in the software sector.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

United Airlines is navigating significant headwinds as the company implements capacity cuts and conducts fuel-price stress tests amidst an escalating geopolitical landscape and potential government-related operational constraints. While the airline reports record-breaking bookings and sustained premium demand, the investment community remains sharply divided, weighing these positive revenue indicators against volatility risks associated with elevated fuel costs and potential infrastructure disruptions.

Rithm Capital Corp. engages in the provision of real estate, credit, and financial services. It operates through the following segments: Origination and Servicing, Investment Portfolio, Residential Transitional Lending, Asset Management, and Corporate. The Origination and Servicing segment includes residential mortgage loans underlying mortgage servicing right assets as well as those sub-service for third parties. The Investment Portfolio segment consists of residential mortgage loans, SFR properties, consumer loans, Non-Agency RMBS, Excess MSRs and servicer advance investments. The Residential Transitional Lending segment competes for both experienced sponsors, including developers and investors in residential real estate, and attractive lending opportunities based on several factors. The Asset Management segment focuses on the wholly owned subsidiaries, Sculptor, and RCM Manager. The company was founded on September 26, 2011 and is headquartered in New York, NY.

Rithm Capital Corporation

Rithm Capital is currently in the spotlight as investors react to its strategic acquisition of Paramount Groups office portfolio and the firm's ongoing transition toward a diversified alternative asset manager. The community is actively debating the impact of these expansion efforts on future dividend sustainability, with many traders closely monitoring the firm's evolving business model as a catalyst for potential long-term value unlocking.

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.

Satellos Bioscience Inc

Satellos Bioscience (MSLE) is trending with its recent NASDAQ listing and a significant equity raise, fueling high anticipation for upcoming clinical updates on its oral therapy, SAT-3247, at a major industry conference. The community is actively debating the 'revolutionary' potential of SAT-3247 to restore muscle repair in Duchenne Muscular Dystrophy, balancing excitement over preclinical data and its novel mechanism against concerns regarding long development timelines and prior dilutions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Century Therapeutics (NASDAQ:IPSC) SVP Sells $17,959.65 in Stock

Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) SVP Douglas Carr sold 7,043 shares of the company's stock in a transaction on Thursday, March 12th. The stock was sold at an average price...

Century Therapeutics (NASDAQ:IPSC) Insider Sells $25,693.80 in Stock

Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) insider Gregory Russotti sold 10,076 shares of the business's stock in a transaction that occurred on Thursday, March 12th. The stock was...

Century Therapeutics, Inc. (NASDAQ:IPSC) Sees Large Growth in Short Interest

Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) was the target of a large increase in short interest during the month of February. As of February 27th, there was short interest totaling...

Century Therapeutics (NASDAQ:IPSC) Announces Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Century Therapeutics (NASDAQ:IPSC - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus...

Century Therapeutics (IPSC) to Release Quarterly Earnings on Wednesday

Century Therapeutics (NASDAQ:IPSC) will be releasing its Q4 2025 earnings before the market opens on Wednesday, March 18. (View Earnings Report at...

Century Therapeutics (NASDAQ:IPSC) Raised to "Hold" at Wall Street Zen

Wall Street Zen upgraded Century Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...

Century Therapeutics, Inc. (NASDAQ:IPSC) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the eight analysts that are presently covering the firm, Marketbeat reports. One...

Century Therapeutics, Inc. (NASDAQ:IPSC) Short Interest Up 39.8% in February

Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) saw a significant increase in short interest during the month of February. As of February 13th, there was short interest totaling 4,739,771...

Century Therapeutics (NASDAQ:IPSC) Now Covered by Analysts at TD Cowen

TD Cowen assumed coverage on shares of Century Therapeutics in a report on Wednesday. They set a "buy" rating for the company...

Short Interest in Century Therapeutics, Inc. (NASDAQ:IPSC) Expands By 320.2%

Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) was the recipient of a significant increase in short interest in the month of January. As of January 30th, there was short interest totaling...

$IPSC Q4 &#39;25 Earnings Results &amp; Recap

Century Therapeutics believes its cash, cash equivalents, and investments of $117.1M as of December 31, 2025, plus $126.7M from a 2026 private placement, will fund operations into Q1 2029.

Stocktwits

Century Therapeutics Inc

 Q4 '25 Earnings Results & Recap

Century Therapeutics believes its cash, cash equivalents, and investments of $117.1M as of December 31, 2025, plus $126.7M from a 2026 private placement, will fund operations into Q1 2029.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.

IPSC
Century Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Earnings Recap

Latest IPSC News

IPSCCentury Therapeutics Inc